Last reviewed · How we verify
Shz QIV 0.5 mL, single dose — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Shz QIV 0.5 mL, single dose (Shz QIV 0.5 mL, single dose) — Sanofi Pasteur, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Shz QIV 0.5 mL, single dose TARGET | Shz QIV 0.5 mL, single dose | Sanofi Pasteur, a Sanofi Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Shz QIV 0.5 mL, single dose CI watch — RSS
- Shz QIV 0.5 mL, single dose CI watch — Atom
- Shz QIV 0.5 mL, single dose CI watch — JSON
- Shz QIV 0.5 mL, single dose alone — RSS
Cite this brief
Drug Landscape (2026). Shz QIV 0.5 mL, single dose — Competitive Intelligence Brief. https://druglandscape.com/ci/shz-qiv-0-5-ml-single-dose. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab